NCT07065552 2026-04-21
Tirzepatide in Obesity-Driven Endometrial Cancer
UNC Lineberger Comprehensive Cancer Center
Phase EARLY_PHASE1 Not yet recruiting
Clinical Trials
9 trialsNCT06751589 2026-04-13
A Study of a Weight Loss Intervention in People With Endometrial Cancer
Memorial Sloan Kettering Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT07228741 2026-04-13
Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity
St. Jude Children's Research Hospital
Phase 2 Recruiting
NCT07257484 2026-03-13
Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors
Weill Medical College of Cornell University
Phase 4 Not yet recruiting
NCT07095517 2026-02-27
PROSPECT
Massachusetts General Hospital
Phase 1 Recruiting
NCT07078838 2026-01-16
Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer
UNC Lineberger Comprehensive Cancer Center
Phase 2 Not yet recruiting
NCT07326111 2026-01-08
PERIODS
University of Bonn
Phase 4 Recruiting
NCT06485089 2025-10-29
Effects of Tirzepatide on Blood, Imaging and Breast Tissue Biomarkers
University of Kansas Medical Center
Active not recruiting
NCT05756764 2025-09-09
Anti-obesity Pharmacotherapy and Inflammation
Louisiana State University Health Sciences Center in New Orleans
Active not recruiting